Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
08/23/2007 | US20070196489 Taste masked pharmaceutical particles |
08/23/2007 | US20070196488 Oral matrix formulations comprising licarbazepine |
08/23/2007 | US20070196487 Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy |
08/23/2007 | US20070196486 Stable oral formulation containing benzimidazole derivative |
08/23/2007 | US20070196485 Stable benzimidazole formulation |
08/23/2007 | US20070196484 Poorly water-soluble drug-containing solid formulation |
08/23/2007 | US20070196483 Taste-Masked Drugs in Rupturing Multiparticulates |
08/23/2007 | US20070196482 a sustained release excipient ( gelling agent waxes, cellulose ether, acrylic polymer, oil, protein derived material, shellac) incorporated into a matrix along with the drug (e.g., torsemide), or applied as a controlled release coating; treatment of edema, congestive heart failure associated with edema |
08/23/2007 | US20070196481 Sustained-release tablet composition |
08/23/2007 | US20070196480 Sustained release formulation for oral administration of hmg-coa reductase inhibitor and method for the preparation thereof |
08/23/2007 | US20070196479 Method For The Timed Dosage Of Medicaments |
08/23/2007 | US20070196478 Antiviral compositions |
08/23/2007 | US20070196477 Rapidly dissolving tablets comprising low surface area calcium phosphates |
08/23/2007 | US20070196476 Rapidly dissolving tablets comprising low surface area titanium dioxide |
08/23/2007 | US20070196475 Rapidly disintegrating low friability tablets comprising silica materials |
08/23/2007 | US20070196474 Rapidly disintegrating low friability tablets comprising calcium carbonate |
08/23/2007 | US20070196473 Pharmaceutical compositions containing flibanserin |
08/23/2007 | US20070196472 Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions |
08/23/2007 | US20070196470 comprising L-Arginine, Xanthinol Nicotinate, and yohimbine; bioavailability; Croscarmellose and/or Crospovidone as agents of disintegration |
08/23/2007 | US20070196469 Magnesium microtablets with sustained release |
08/23/2007 | US20070196468 Simethicone solid oral dosage form |
08/23/2007 | US20070196467 Indium supplement compositions and methods therefor |
08/23/2007 | US20070196466 Pharmaceutical formulations containing flavouring substances with improved pharmaceutical properties |
08/23/2007 | US20070196465 Treatment with dihydropyridine calcium channel blockers and omega-3 fatty acids and a combination product thereof |
08/23/2007 | US20070196464 Bioavailability; absorption; using fatty acid, or salt thereof, or fatty ester |
08/23/2007 | US20070196463 Enteric Soft Gelatin Capsule Containing Esomerpazole And Method Of Preparation |
08/23/2007 | US20070196462 Composition and method for neuromuscular blockade |
08/23/2007 | US20070196461 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof |
08/23/2007 | US20070196460 External preparation for treating skin or mucosal injury caused by viral infection |
08/23/2007 | US20070196455 Crosslinkable pressure-sensitive adhesive for skin |
08/23/2007 | US20070196453 Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs |
08/23/2007 | US20070196452 Flux-enabling compositions and methods for dermal delivery of drugs |
08/23/2007 | US20070196451 Extendable rolled delivery system |
08/23/2007 | US20070196450 Delivery system for topical medications |
08/23/2007 | US20070196447 such as nystatin and flavor modifier; chewable dosages |
08/23/2007 | US20070196446 Conjugated fatty acid esters |
08/23/2007 | US20070196444 Pantoprazole multiparticulate formulations |
08/23/2007 | US20070196443 Spherical core with enteric overcoating; antiulcer agents |
08/23/2007 | US20070196441 Process for Making Orally Consumable Dosage Forms |
08/23/2007 | US20070196433 Methods and devices for the sustained release of multiple drugs |
08/23/2007 | US20070196427 Method for preparing adjustably bioresorbable sol-gel derived sio2 |
08/23/2007 | US20070196425 Thermosensitive and biodegradable microgel and a method for the preparation thereof |
08/23/2007 | US20070196419 Composite Materials Based On Polysilicic Acid And Method For The Production Thereof |
08/23/2007 | US20070196417 Therapeutic polyanhydride compounds for drug delivery |
08/23/2007 | US20070196410 Slow-Release Microcapsule Composition for Safe Delivery of Agriculturally Active Material |
08/23/2007 | US20070196401 Nano-Fiber Compound Solutions, Emulsions And Gels, Production Method Thereof, Nano-Fiber Synthetic Papers, And Production Method Thereof |
08/23/2007 | US20070196399 Enteric-coated preparation covered with enteric coating material for site-specific delivery of drug to site within the small intestine |
08/23/2007 | US20070196397 Method And Device For Producing Micro-Droplets |
08/23/2007 | US20070196396 Controlled release pharmaceutical compositions with improved bioavailability |
08/23/2007 | US20070196391 Mucosal boosting following parenteral priming |
08/23/2007 | US20070196342 Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects |
08/23/2007 | US20070196333 Composition comprising mixtures of IFN-alpha subtypes |
08/23/2007 | US20070196286 Aerosol composition comprising formoterol |
08/23/2007 | US20070196285 Novel combination of anticholinergics - B2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases |
08/23/2007 | US20070196284 Micelles associated to outer surface of liposome envelope by electrostatic interaction; active compound incorporated into the micelles linking a large amount of active compound to a single liposome carrier; bioavailability; image-enhanced contrast agents for imaging (MRI); tissue-targeted therapy |
08/23/2007 | US20070196283 Composition for transfection of DNA into the liver |
08/23/2007 | DE102006006532A1 Pharmazeutische Zubereitung Pharmaceutical composition |
08/23/2007 | DE102006006510A1 Lokales Wirkstofffreisetzungssystem und ein Verfahren zu seiner Herstellung Local drug release system and a process for its preparation |
08/23/2007 | DE102006006413A1 UV-Filter-Kapsel UV filter capsule |
08/23/2007 | CA2838399A1 Formulations for a tight junction effector |
08/23/2007 | CA2649265A1 Microparticulate pharmaceutical forms resistant to immediate release of the active principle in the presence of alcohol |
08/23/2007 | CA2643327A1 Press-fit rapid release medicament and method and apparatus of manufacturing |
08/23/2007 | CA2642785A1 Passive time released solute treatment |
08/23/2007 | CA2642641A1 Stable corticosteroid mixtures |
08/23/2007 | CA2642579A1 Sterilization of corticosteroids with reduced mass loss |
08/23/2007 | CA2642414A1 Rapid release irbesartan-containing pharmaceutical composition |
08/23/2007 | CA2642338A1 Adhesive preparation comprising sufentanil and methods of using the same |
08/23/2007 | CA2642255A1 Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture |
08/23/2007 | CA2642042A1 Radio frequency induced drug elution |
08/23/2007 | CA2641950A1 All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization |
08/23/2007 | CA2641906A1 Applications of microencapsulated essential oils |
08/23/2007 | CA2641616A1 Pharmaceutical formulations |
08/23/2007 | CA2641605A1 Pharmaceutical formulations |
08/23/2007 | CA2641604A1 Pharmaceutical formulations |
08/23/2007 | CA2640560A1 Joining and/or sealing tissues through photo-activated cross-linking of matrix proteins |
08/23/2007 | CA2640243A1 Disintegrable oral films |
08/23/2007 | CA2633588A1 Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same |
08/23/2007 | CA2556305A1 Rapidly dissolving solid oral dosage form for delivery of composition for increasing nitric oxide activity |
08/22/2007 | EP1820516A2 Novel albumin-free factor VIII formulations |
08/22/2007 | EP1820507A1 A pharmaceutical composition for the medical treatment of the benign prostatic hyperplasia, its preparation method and its therapeutical application |
08/22/2007 | EP1820506A1 Dipyridamole extended-release formulations and process for preparing same |
08/22/2007 | EP1820498A2 Enteric-coated preparation for site-specific delivery of drug to site within the small intestine |
08/22/2007 | EP1820497A2 Effervescent bisphosphonate formulation |
08/22/2007 | EP1820496A2 Implant material |
08/22/2007 | EP1820495A2 Microspheres for active embolization |
08/22/2007 | EP1820494A2 Microspheres of estradiol and cholesterol |
08/22/2007 | EP1820493A2 Aerosols for sinunasal drug delivery |
08/22/2007 | EP1819362A2 Topical nepafenac formulations |
08/22/2007 | EP1819352A1 Pharmaceutical compositions from carapa guianensis |
08/22/2007 | EP1819324A1 Solid particles from controlled destabilisation of microemulsions |
08/22/2007 | EP1819323A2 Pharmaceutical composition containing an anti-nucleating agent |
08/22/2007 | EP1819322A2 Formulations of substituted benzoxazoles |
08/22/2007 | EP1819321A2 Formulations of substituted benzoxazoles |
08/22/2007 | EP1819320A1 Orally dispersible pharmaceutical composition and process for the preparation thereof |
08/22/2007 | EP1819319A1 Pharmaceutical compositions of amorphous atorvastatin and process for preparing same |
08/22/2007 | EP1819318A1 Dried forms of aqueous solubilized bile acid dosage formulation |
08/22/2007 | EP1819297A2 Uv cured gel and method of making |
08/22/2007 | EP1819289A1 Controlled ocular lens regeneration |
08/22/2007 | EP1691745A4 Methods and compositions for treating skin wounds |
08/22/2007 | EP1684851B1 Methods for preparing polymeric buffer formulations for electrotransport applications |